在“十二五”规划中,对医药领域制定了全面的蓝图,涵盖生物医药、医疗器械、医药流通等等领域。在新医改扩大、专利药过保等国内外利好之下,号称“跑步进入春天”的国内医药领域迎来了新的时代。为此,本文选取了两家生物医药企业、一家医疗器械企业以及一 In the “12th Five-Year Plan,” we have formulated a comprehensive blueprint for the field of medicine and covered areas such as biomedicine, medical devices, pharmaceutical distribution and so on. In the new medical reform to expand, patent drug insurance and other favorable conditions at home and abroad, known as “running into the spring ” the domestic medical field ushered in a new era. To this end, this article selected two biomedical companies, a medical device business and one